RYAHF (RYAH Group) OCF Margin %: -1,450.00% (As of Sep. 2022)


What is RYAH Group OCF Margin %?

RYAH Group RYAHF OCF Margin % is -1,450.00% as of Sep. 2022.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. RYAH Group's Cash Flow from Operations for the three months ended in Sep. 2022 was $-0.12 Mil. RYAH Group's Revenue for the three months ended in Sep. 2022 was $0.01 Mil. Therefore, RYAH Group's OCF Margin % for the quarter that ended in Sep. 2022 was -1,450.00%.

As of today, RYAH Group's current OCF Yield % is 0.00%.

The historical rank and industry rank for RYAH Group's OCF Margin % or its related term are showing as below:

RYAHF' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -483.2

RYAHF's OCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 8.33 vs RYAHF: -483.20

RYAH Group OCF Margin % Related Terms

RYAH Group OCF Margin % Historical Data

* Premium members only.

The historical data trend for RYAH Group's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group OCF Margin % Chart

RYAH Group Annual Data
Trend Dec20 Dec21
OCF Margin %
-1,132.56 -1,883.93

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -571.43 -1,450.00

RYAHF vs CERN, VEEV, CHNG: OCF Margin % Comparison

For the Health Information Services subindustry, RYAH Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RYAH Group OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's OCF Margin % distribution charts can be found below:

* The bar in red indicates where RYAH Group's OCF Margin % falls into.


RYAH Group OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

RYAH Group's OCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-3.165/0.168
=-1,883.93 %

RYAH Group's OCF Margin for the quarter that ended in Sep. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-0.116/0.008
=-1,450.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1,450.00% mean?
RYAH Group (RYAHF) has a OCF Margin % of -1,450.00% as of Sep. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RYAH Group and its competitors.
Is RYAH Group's OCF Margin % too high?
RYAH Group's current OCF Margin % is -1,450.00%.
How does RYAH Group's OCF Margin % compare to CERN and VEEV?
RYAH Group's OCF Margin % of -1,450.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median OCF Margin % is 8.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.33, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RYAH Group and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RYAH Group's current OCF Margin % is -1,450.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current OCF Margin % of -1,450.00%. The current OCF Margin % is -1,450.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For RYAH Group (RYAHF), the current OCF Margin % is -1,450.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.